L-P Xu
Overview
Explore the profile of L-P Xu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
791
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yao W, Wen Q, Zhao H, Tang S, Zhang Y, Wang Y, et al.
Clin Exp Immunol
. 2020 Oct;
203(1):137-149.
PMID: 33020903
Young donors are reported to be associated with better transplant outcomes than older donors in allogeneic hematopoietic stem cell transplantation (allo-HSCT), but the mechanism is still unclear. The current study...
2.
Xu L, Xu Z, Wang F, Mo X, Han T, Han W, et al.
Bone Marrow Transplant
. 2018 Jan;
53(2):188-192.
PMID: 29334367
We conducted a retrospective analysis to evaluate outcomes of haploidentical transplantation in adult severe aplastic anaemia (SAA) patients. Fifty-one adults received haploidentical transplantation between May 2011 and December 2016. Patients...
3.
Cao L, Liu L, Xu L, Zhang X, Wang Y, Fan Q, et al.
Bone Marrow Transplant
. 2017 Oct;
53(1):108-110.
PMID: 29058700
No abstract available.
4.
Pei X, Zhao X, Xu L, Wang Y, Zhang X, Chang Y, et al.
Bone Marrow Transplant
. 2017 Aug;
52(11):1556-1562.
PMID: 28805792
Immune recovery (IR) after haploidentical stem cell transplantation (haplo-SCT) in severe aplastic anemia (SAA) patients remains relatively unknown. In this study, we examined immune cell subset counts and immunoglobulins in...
5.
Wang Y, Wu D, Liu Q, Xu L, Liu K, Zhang X, et al.
Leukemia
. 2017 Jun;
32(2):492-498.
PMID: 28642591
Prior data indicate similar outcomes after transplants from human leukocyte antigen (HLA)-haplotype-matched relatives, HLA-identical siblings and HLA-matched unrelated donors. We used our prospective data set to answer a clinically important...
6.
Xu L, Wu D, Han M, Huang H, Liu Q, Liu D, et al.
Bone Marrow Transplant
. 2017 Apr;
52(11):1512-1518.
PMID: 28436973
Hematopoietic cell transplantation (HCT) activity in China was surveyed to assess its current status. A record number of HCTs (21 884: 16 631 allogeneic (76%) and 5253 autologous (24%)) were...
7.
Yang X, Wang C, He X, Wei J, Wang Y, Li X, et al.
Climacteric
. 2017 Apr;
20(3):268-273.
PMID: 28399661
Objectives: The current usage of hormone therapy (HT) among perimenopausal women is low in China, especial in women with premature ovarian insufficiency (POI) with malignant hematologic diseases. This study investigated...
8.
Bian Z, Liu J, Xu L, Chang Y, Wang Y, Zhang X, et al.
Bone Marrow Transplant
. 2016 Nov;
52(2):264-269.
PMID: 27797369
EBV infection is one of the life-threatening clinical complications in patients who underwent haploidentical hematopoietic stem cell transplantation (haploHSCT). Although immune recovery is recognized to be crucial for decreasing subsequent...
9.
Ma Y, Xu L, Zhang X, Yan C, Wang Y, Wang F, et al.
Bone Marrow Transplant
. 2016 Nov;
52(3):409-414.
PMID: 27797365
We investigated the impact of donor type on post-relapse survival (PRS) in 85 patients with hematological relapse after their first allogeneic hematological stem cell transplantation (allo-HSCT) for hematological malignancy. The...
10.
Mo X, Zhang X, Xu L, Wang Y, Yan C, Chen H, et al.
Transpl Infect Dis
. 2016 May;
18(4):492-503.
PMID: 27218435
Background: In this study, we aimed to evaluate the prognostic factors associated with and treatments for late-onset severe pneumonia (LOSP) in patients who underwent allogeneic hematopoietic stem cell transplantation (allo-HSCT)....